Optiver Holding
SGMO

Optiver Holding’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Optiver Holding’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,200
Closed -$790 – 3053
2026
Q1 		$790 Hold
3,200
– – ﹤0.01% 2097
2025
Q4 		$1.34K Hold
3,200
– – ﹤0.01% 2155
2025
Q3 		$2.15K Hold
3,200
– – ﹤0.01% 2360
2025
Q2 		$1.73K Hold
3,200
– – ﹤0.01% 1358
2025
Q1 		$2.1K Hold
3,200
– – ﹤0.01% 1233
2024
Q4 		$3.26K Hold
3,200
– – ﹤0.01% 905
2024
Q3 		$2.77K Hold
3,200
– – ﹤0.01% 842
2024
Q2 		$1.15K Buy
+3,200
New +$1.73K ﹤0.01% 861
2022
Q2 		– Sell
-1,442
Closed -$8K – 509
2022
Q1 		$8K Buy
1,442
+805
+126% +$4.79K ﹤0.01% 441
2021
Q4 		$5K Buy
+637
New +$5.53K ﹤0.01% 785

Other funds holding SGMO

NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
AIM
Axiom Investment Management New York $150M AUM
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
HIG
Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Optiver Holding's SGMO Position: Q2 2026 in Review

Optiver Holding sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 3,200 shares — an estimated $790 sold.

Optiver Holding first reported a position in SGMO in Q4 2021 and held it in 10 quarters. The position peaked at $8K in Q1 2022. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Optiver Holding reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 3,200 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $790.
  • Optiver Holding first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 10 quarters.
  • Optiver Holding's SANGAMO THERAPEUTICS INC position peaked at $8K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.